Filing Details
- Accession Number:
- 0001209191-22-034992
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2022-06-08 16:01:51
- Reporting Period:
- 2022-06-03
- Accepted Time:
- 2022-06-08 16:01:51
- Original Submission Date:
- 2022-06-06
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1434316 | Fate Therapeutics Inc | FATE | Biological Products, (No Disgnostic Substances) (2836) | 651311552 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1746830 | Shefali Agarwal | C/O Fate Therapeutics, Inc. 12278 Scripps Summit Drive San Diego CA 92131 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2022-06-03 | 0 | $0.00 | 2,681 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Corrected to reflect that no shares were sold on June 3, 2022.
Billionaire Hedge Funds
